| Sam J Hudson, | |
|
1803 Whites Rd, Suite 1-b, Kalamazoo, MI 49008-2883 | |
| (269) 373-7585 | |
| (269) 363-7588 |
| Full Name | Sam J Hudson |
|---|---|
| Gender | Male |
| Speciality | Qualified Audiologist |
| Experience | 30 Years |
| Location | 1803 Whites Rd, Kalamazoo, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922201250 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 1601000464 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Paragon Health Pc | 1658283007 | 43 |
News Archive
Argos Therapeutics today announced two oral presentations detailing data on its soluble CD83 (sCD83) protein program at the 2010 American Transplant Congress, held May 1-5 in San Diego. The data, which were produced by Argos in collaboration with scientists from the University of Western Ontario, demonstrate that sCD83 is capable of inducing immune system tolerance to transplant grafts and suppressing an anti-donor antibody response, via a multi-faceted mechanism-of-action that impacts B and T cells, as well as dendritic cells.
Heating up cancer cells while targeting them with chemotherapy is a highly effective way of killing them, according to a new study led by UCL researchers.
Whole genome sequencing of the DNA code of prenatal samples accurately and quickly identifies the location of chromosomal abnormalities, and could become a prenatal standard of care, researchers propose.
Pharmacyclics, Inc. today announced results from a Phase II trial of the investigational oral agent ibrutinib which demonstrated rapid and sustained disease control as a monotherapy in untreated, relapsed and refractory chronic lymphocytic leukemia (CLL) patients, irrespective of characteristics that predict poor outcomes to chemoimmunotherapy.
› Verified 1 days ago
| Provider Name | Paragon Health Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1275582249 PECOS PAC ID: 1658283007 Enrollment ID: O20040706000913 |
News Archive
Argos Therapeutics today announced two oral presentations detailing data on its soluble CD83 (sCD83) protein program at the 2010 American Transplant Congress, held May 1-5 in San Diego. The data, which were produced by Argos in collaboration with scientists from the University of Western Ontario, demonstrate that sCD83 is capable of inducing immune system tolerance to transplant grafts and suppressing an anti-donor antibody response, via a multi-faceted mechanism-of-action that impacts B and T cells, as well as dendritic cells.
Heating up cancer cells while targeting them with chemotherapy is a highly effective way of killing them, according to a new study led by UCL researchers.
Whole genome sequencing of the DNA code of prenatal samples accurately and quickly identifies the location of chromosomal abnormalities, and could become a prenatal standard of care, researchers propose.
Pharmacyclics, Inc. today announced results from a Phase II trial of the investigational oral agent ibrutinib which demonstrated rapid and sustained disease control as a monotherapy in untreated, relapsed and refractory chronic lymphocytic leukemia (CLL) patients, irrespective of characteristics that predict poor outcomes to chemoimmunotherapy.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sam J Hudson, 695 S Us Highway 131, Three Rivers, MI 49093-8831 Ph: (269) 858-3311 | Sam J Hudson, 1803 Whites Rd, Suite 1-b, Kalamazoo, MI 49008-2883 Ph: (269) 373-7585 |
News Archive
Argos Therapeutics today announced two oral presentations detailing data on its soluble CD83 (sCD83) protein program at the 2010 American Transplant Congress, held May 1-5 in San Diego. The data, which were produced by Argos in collaboration with scientists from the University of Western Ontario, demonstrate that sCD83 is capable of inducing immune system tolerance to transplant grafts and suppressing an anti-donor antibody response, via a multi-faceted mechanism-of-action that impacts B and T cells, as well as dendritic cells.
Heating up cancer cells while targeting them with chemotherapy is a highly effective way of killing them, according to a new study led by UCL researchers.
Whole genome sequencing of the DNA code of prenatal samples accurately and quickly identifies the location of chromosomal abnormalities, and could become a prenatal standard of care, researchers propose.
Pharmacyclics, Inc. today announced results from a Phase II trial of the investigational oral agent ibrutinib which demonstrated rapid and sustained disease control as a monotherapy in untreated, relapsed and refractory chronic lymphocytic leukemia (CLL) patients, irrespective of characteristics that predict poor outcomes to chemoimmunotherapy.
› Verified 1 days ago
Scott Andrew Hansson, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Oakland Dr, Kalamazoo, MI 49008 Phone: 269-387-7000 | |
Nancy Ann Gallihugh, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1634 Gull Rd, Kalamazoo, MI 49048 Phone: 269-343-2601 | |
Ms. Teresa B Crumpton, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1000 Oakland Dr Fl 3, Kalamazoo, MI 49008 Phone: 269-387-7000 Fax: 269-387-7026 | |
Dr. Mary Elizabeth Peterson, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Oakland Dr Fl 3, Wmu Unified Clinics Charles Van Riper Language Speech, Kalamazoo, MI 49008 Phone: 269-387-7209 Fax: 269-387-7227 | |
Kathryn Louise Hamann, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1634 Gull Rd, Kalamazoo, MI 49048 Phone: 269-343-2601 | |
Kimberly Anne Kragt, MA, CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1634 Gull Rd Lowr 201, Kalamazoo, MI 49048 Phone: 269-343-2601 | |
Sandra Almlie, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1634 Gull Rd, Suite 201, Kalamazoo, MI 49048 Phone: 269-343-2601 Fax: 269-343-9257 |